Olu Pain Management Patch

Manufacturer
Asclemed USA, Inc. | ASCLEMED USA INC. DBA ENOVACHEM
Effective date
2025-04-01
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 00:58:38

Label at a glance#

ProductOlu Pain Management
Active ingredientCAMPHOR (NATURAL), LIDOCAINE
Label structure19 sections

Indications and uses

For the temporary relief of muscle pain and joint pain associated with: -Backache -Cramps -Soreness -Strains -Discomfort -Neckache

Dosage and administration

Adults and Children 12 Years of Age and Older: -Clean and dry the affected area -Apply gel pad directly onto skin for up to 12 hours -Wash hands immediately after use -Gel pad can be cut into pieces and used on up to 2 body parts at a time -One application per day is recommended

Label contents#

Full prescribing information#

ACTIVE INGREDIENTS

OTC - ACTIVE INGREDIENT SECTION

Lidocaine 4%

PURPOSE

OTC - PURPOSE SECTION

Local Anesthetic

ACTIVE INGREDIENTS

OTC - ACTIVE INGREDIENT SECTION

Camphor 1%

PURPOSE

OTC - PURPOSE SECTION

Counterirritant

USES

INDICATIONS & USAGE SECTION

For the temporary relief of muscle pain and joint pain associated with:

-Backache -Cramps -Soreness -Strains -Discomfort -Neckache

WARNINGS:

WARNINGS SECTION

FOR EXTERNAL USE ONLY

ALLERGY ALERT

SPL UNCLASSIFIED SECTION

Local anesthetics may cause methemoglobinemia. If an allergic reaction occurs, stop use and seek medical attention immediately.

DO NOT USE

OTC - DO NOT USE SECTION

-On damaged, irritated, or infected skin

-With a bandage or heating pad

-If you are allergic to any ingredients in this product

-In the eyes, nose, or mouth

-Otherwise as directed

WHEN USING THIS PRODUCT

OTC - WHEN USING SECTION

Avoid contact with the eyes, nose, and mouth

STOP USE AND ASK DOCTOR IF

OTC - STOP USE SECTION

-Any of the warnings apply to you

-Excessive skin irritation develops

-Condition worsens

-Symptoms persist for more than 7 days, or symptoms clear up and occur again within 3 days

IF PREGNANT OR BREASTFEEDING

OTC - PREGNANCY OR BREAST FEEDING SECTION

Ask a healthcare professional before use

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If ingested, seek medical help or contact Poison Control immediately

FLAMMABLE

SPL UNCLASSIFIED SECTION

Keep away from excessive heat or open flame

DIRECTIONS

DOSAGE & ADMINISTRATION SECTION

Adults and Children 12 Years of Age and Older:

-Clean and dry the affected area

-Apply gel pad directly onto skin for up to 12 hours

-Wash hands immediately after use

-Gel pad can be cut into pieces and used on up to 2 body parts at a time

-One application per day is recommended

OTHER INFORMATION

SPL UNCLASSIFIED SECTION

-Store in a cool, dry place with pouch tightly closed. Keep from freezing.

-If the tamper-evident foil seal is not intact, do not use

INACTIVE INGREDIENTS

INACTIVE INGREDIENT SECTION

Arnica Extract, Boswellia Extract, Vitamin C, Vitamin E, Ethyl Alcohol, Propylene Glycol, Glycerol, Sodium Polyacrylate, Tartaric Acid, Dihydroxyaluminium Aminoacetate, Methylparaben, Water

QUESTIONS OR COMMENTS

SPL UNCLASSIFIED SECTION

info@olakinotherapeutics.com

SPL UNCLASSIFIED SECTION

Relabeled by:

Enovachem PHARMACEUTICALS

Torrance, CA 90501

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

labellabel

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
2700664camphor 1 % / lidocaine 4 % Medicated PatchPSN1
2700664camphor 0.01 MG/MG / lidocaine 0.04 MG/MG Medicated PatchSCD1
2700664camphor 1 % / lidocaine 4 % Medicated PatchSY1

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
LIDOCAINE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
f52be47f-7aa7-46c0-b1fa-50c18dd50206Product name120201029

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
76420-956-05Olu Pain Management8.5 g in 1 PATCHPATCH8.51
76420-956-05Olu Pain Management5 in 1 POUCHPATCH51
76420-956-15Olu Pain Management5 in 1 POUCHPATCH51
76420-956-15Olu Pain Management3 in 1 BOXPATCH31

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
76420-956OLU PAIN MANAGEMENT (LIDOCAINE AND CAMPHOR) PATCH [ASCLEMED USA, INC.]1Current NDC, 4 package rows20250406_d4d556c1-b64b-4b8e-8e4b-4f40eda24250.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
84991-0208-1EA - Each84991-020814a60efa-e657-494d-8cae-20f4205b279612025-03-04

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 16 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
76420-95676420-956-15, 76420-956-05
84991-0208

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 14 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Olu Pain ManagementLIDOCAINE AND CAMPHORAsclemed USA, Inc.d4d556c1-b64b-4b8e-8e4b-4f40eda242502025-04-01WarningsExact identifier
ndc (package): 76420-956-15
ndc (package): 76420-956-05
ndc (product): 76420-956
ndc11 (package): 76420095605
ndc11 (package): 76420095615
spl id: 31b1821f-f265-221a-e063-6394a90ae56d
spl set id: d4d556c1-b64b-4b8e-8e4b-4f40eda24250
Olu Pain ManagementLIDOCAINE AND CAMPHOROlakino Therapeutics LLC2a41a621-c6f7-5819-e063-6394a90ae67d2025-02-07WarningsExact identifier
ndc (product): 84991-0208

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.